YM Biosciences

The chairman and chief executive officer (CEO) of Ontario-based YM Biosciences (YM), was preparing for the upcoming board meeting. During this meeting several items of strategic importance would be discussed. Two potential acquisitions were being contemplated. In order to prepare for this meeting, the chairman would have to assess the strategic impact of each of the potential acquisitions and the way in which the acquisitions should be conducted.